Quiroz-Reyes Adriana G, Islas Jose F, Delgado-Gonzalez Paulina, Franco-Villarreal Hector, Garza-Treviño Elsa N
Biochemistry and Molecular Medicine Department, School of Medicine, Universidad Autonoma de Nuevo Leon, Monterrey 64460, Mexico.
Althian Clinical Research, Monterrey 64000, Mexico.
Pharmaceutics. 2021 Jan 14;13(1):103. doi: 10.3390/pharmaceutics13010103.
Metastasis is the process of dissemination of a tumor, whereby cells from the primary site dislodge and find their way to other tissues where secondary tumors establish. Metastasis is the primary cause of death related to cancer. This process warrants changes in original tumoral cells and their microenvironment to establish a metastatic niche. Traditionally, cancer therapy has focused on metastasis prevention by systematic treatments or direct surgical re-sectioning. However, metastasis can still occur. More recently, new therapies direct their attention to targeting cancer stem cells. As they propose, these cells could be the orchestrators of the metastatic niche. In this review, we describe conventional and novel developments in cancer therapeutics for liver and lung metastasis. We further discuss the resistance mechanisms of targeted therapy, the advantages, and disadvantages of diverse treatment approaches, and future novel strategies to enhance cancer prognosis.
转移是肿瘤扩散的过程,即原发部位的细胞脱离并迁移至其他组织,在那里形成继发性肿瘤。转移是癌症相关死亡的主要原因。这一过程需要原发肿瘤细胞及其微环境发生变化,以建立转移小生境。传统上,癌症治疗主要集中于通过全身治疗或直接手术切除来预防转移。然而,转移仍可能发生。最近,新的治疗方法将注意力转向靶向癌症干细胞。正如他们所提出的,这些细胞可能是转移小生境的组织者。在这篇综述中,我们描述了针对肝转移和肺转移的癌症治疗的传统和新进展。我们还讨论了靶向治疗的耐药机制、不同治疗方法的优缺点以及改善癌症预后的未来新策略。